<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>SAP is an adaptor molecule with one SH2 domain and it is expressed in activated T and NK cells, where it is required for the appropriate signaling from the SLAM family of surface receptors </plain></SENT>
<SENT sid="1" pm="."><plain>Deleted or mutated SAP genes that encode functionally defective protein are associated with the <z:hpo ids='HP_0001417'>X-linked</z:hpo> <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative disease</z:e> (XLP) </plain></SENT>
<SENT sid="2" pm="."><plain>This primary <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> is characterized by extreme sensitivity to Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, <z:hpo ids='HP_0002961'>dysgammaglobulinemia</z:hpo> and a high rate of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> development </plain></SENT>
<SENT sid="3" pm="."><plain>The vigorous T- and B-cell proliferation that follows <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> and the high incidence of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (30%) in XLP patients might reflect functional defects in cell cycle and/ or <z:mpath ids='MPATH_3'>apoptosis</z:mpath> control </plain></SENT>
<SENT sid="4" pm="."><plain>Our experiments show that SAP is a target of p53 </plain></SENT>
<SENT sid="5" pm="."><plain>In Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) lines transfected with a temperatur-sensitive (ts) p53, SAP <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expression was dependent on <z:mp ids='MP_0002169'>wild-type</z:mp> (wt) p53 </plain></SENT>
<SENT sid="6" pm="."><plain>Activation of endogenous wt p53 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BLs</z:e> and lymphoblastoid cell lines led to the induction of SAP and this was inhibited by the specific p53 inhibitor pifithrin-alpha </plain></SENT>
<SENT sid="7" pm="."><plain>Cell lines that carried mutant p53 did not express SAP under similar conditions </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, we have shown binding of wt p53 to the promoter region of SAP by ChIP assay </plain></SENT>
<SENT sid="9" pm="."><plain>Our results suggest that SAP contributes to the execution of some p53 functions </plain></SENT>
</text></document>